Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
You must have this message on your clipboard
SP can move on anything and any direction to any magnitude. The MM and institutional investors, day traders who make the price move will not pause one microsecond to weigh whether SPURT 19 thinks the company has the credibility to move the share price on news, amigo. Go with God my friend, peace be with you, use the force, hairy krishna, hairy yetis, and all that noise. Happy independence day.
Master said you'd say that
Aye sed it al allong
Eye wood knot inn vest dis cum pony unteel it gotz sails..
6 yetis are better than 7
Titan only needs a one holed bowling ball
I put all my shares up for sale this afternoon for $3.65 USD nobody bought them
Define "roll some ball"
Could well be, but why on a short holiday week?
I noticed 29k fb likes of the bizpedia entry for enos...that's a lot.
Having thought some more about it, I believe enos is the new name for the robot not the software. From the application, it states for surgical systems not software specifically:
[quoute]requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:
International Class 010: Computer-assisted surgical systems comprised of a surgeon's workstation, video display, controllers, and patient cart; Computer-assisted surgical device and apparatus, including endoscopic cameras, surgical instruments, electrosurgical products, and surgical products, including drapes
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.[/quote]
https://tsdr.uspto.gov/documentviewer?caseId=sn88444220&docId=RFA20190527085818#docIndex=0&page=1
Even the crape myrtle was once a crape myrtle seed
Yea it would make sense the "os" stands for operating system or operating software
You're being too literal man, use you abstract thinking...point is even the mighty oak was once an acorn. Peace be with you
Thanks - we need some perpective in this discussion
I tend to agree with this, if for no other reason than human studies takes a while. People aren't readily available like pigs or dogs from a farm. And the protocols are more involved, plus going through the IRB at hospitals takes time. Then you have to observe post op. It's not a one and done. Unless there's some zippy protocol they plan to use that I've never heard of. It's possible the bureaucratic drag could be reduced if titan already set up everything with the 3 CsOE. Is anyone aware if this is true?
What if? So what?
I reject the notion that one is not "qualified" to discuss such matters because they are not a lawyer. So you can't say cancer is bad because you've never had it?
Investors are not entitled to all information, companies need discretion to maintain conpetitive advantages. But here we are again back at the claim that anticipated timelines are scripture...no defrauding investors there pal. Sorry. Wake me up when they are cooking the books.
Losing money on a stock is not grounds for a suit, sorry. It always has been and always will be buyer beware. If you are foolish enough to lose millions on a sibgle stock it's your own fault. Reality, man.
Not arrogant, educated. I've studied business law. You are the one stating they are guilty and must prove their innocence based on your hunch - what's more arrogant?
Insider trading is gray. There is no evidence of fraud or resulting material damages (to which shareholders had a right). The end. Good night.
No, because I'm mot a loser who has to try and make money with ridiculous torts.
Ps you are admitting there is frivolity to the claim
Exactly why we need a loser pays system.
You cannot link that to any material damages...every time a company's reputation is harmed, it's an act of defrauding the investors? It makes no sense.
The former is a nothingburger. The later is a huge stretch. No case my friend. I would bet all my TMDI shares even buttlick and associates would not touch a case against Titan because it would be a total waste of time.
Nepotism is not illegal. Wow.
Haha because that will recoup your losses...pierce the corporate veil and make the company so toxic for senior leadership that once the current board is out, no C-level talent worth a darn will touch it with a 10ft pole. Brilliant. We are the most litigious society on earth, and it's a terrible thing. Besides there is no case here and if you believe so its out of ignorance, I'm sorry to say.
I don't see how that proves a lie. Is it not possible that the redesign fit into the anticpated timeline for clearance by end of 2018?
Can we sticky a good post with link to ENOS registry?
Man if you were right all along there are a lot of people here, myself included who will eat crow for giving you a hard time. Mucho hosannas.
Yeppers
As mentioned on ST...ENOS = EthicoN Operating System?!
lol @ CLETUS
It's too close to ANUS
Titan has atomic surgery capability
Reviewing the timeline, they have this week to announce animal GLP study commencement, in order to still be on track. Will they make the announcement this week?
Thank you for gracing us with your presence. We were all wondering what you thought, and whether you would stay.
Looking back a short position a few years ago would've really paid off at this point. Not knowing how things would pan out, as a fund manager I would've participated in a private offering at a discounted price with a simultaneous short position in the higher priced open market (PIPE hedge). I always have and will continue to say Titan is a gambit until years of regular sales growth. I believe the product will be innovative and cost competitive enough to accomplish profitability over the next couple of decades, beginning if and when they cross the FDA finish line.